MENINGOCOCCAL MENINGITIS

More documents

Recommendations

Info

Purpose of surveillance Detect outbreaks early Estimate the number of cases and deaths Assess size and geographic extent of outbreak Plan vaccination campaign Describe if control measures are working
Collect Information Record basic information Date, name, age, gender, address Record basic information Diagnosis and method of confirmation CLINICAL Diagnosis and method of confirmation LABORATORY Treatment LABORATORY Treatment Outcome Consider separate epidemic register during an epidemic (Attack rate substantially above the usual rate)
Page 1 and 2: MENINGOCOCCAL MENINGITIS Dr. Charma
Page 3 and 4: Types of Meningitis
Page 5 and 6: Meningococcal Disease Severe bacte
Page 7 and 8: Aetiological agent The causative a
Page 9 and 10: Neisseria meningitidis 3 serogroups
Page 11 and 12: Nasopharyngeal carriage Neisseria
Page 13 and 14: Incubation period and Infectivity
Page 15 and 16: Signs and Symptoms Meningococcal Me
Page 17 and 18: Petechial rash
Page 19 and 20: Necrotic rash
Page 21 and 22: Petechial rash
Page 23 and 24: Other signs and symptoms Acute fev
Page 25 and 26: “Meningitis Meningitis belt” be
Page 27: Meningococcal disease Statuatory n
Page 31 and 32: Case ascertainment EU Case Definit
Page 33 and 34: Case classification Probable case:
Page 35 and 36: Family Slide
Page 37 and 38: Prophylactic treatment Risk assess
Page 39 and 40: Prophylaxis NOT indicated Staff an
Page 41 and 42: Chemoprophylaxis : CIPROFLOXACIN 5
Page 43 and 44: Dissemination of information House
Page 45 and 46: Managing clusters Assess the infor
Page 47 and 48: Control Strategy Communicable dise
Page 49 and 50: Case fatality rate Proportion of c
Page 51 and 52: AGE SPECIFIC INCIDENCE RATES Incide
Page 53: Thank you charmaine.gauci@gov.mt

MENINGOCOCCAL MENINGITIS

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?